Advanced search
Publication Cover
Modern Rheumatology Case Reports Volume 3, 2019 - Issue 1
Journal homepage
72
Views
0
CrossRef citations to date
0
Altmetric
Case Report

Four cases of HLA-A*26(+)/B*51(−) intestinal Behçet’s disease without abdominal symptoms

Tsuyoshi KobashigawaInstitute of Rheumatology, Tokyo Women’s Medical University, Tokyo, JapanCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0001-7438-5220
ORCID Icon,
Yuki NankeInstitute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan
,
Hisashi YamanakaInstitute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan
&
Shigeru KotakeInstitute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan
Pages 38-44 | Received 03 Aug 2017, Accepted 01 Feb 2018, Published online: 17 Jul 2018

References

  • Kobashigawa T, Nanke Y, Oda H, et al. Bowel lesions of Behçet’s disease are frequently detected in non-ileocecal regions as well as in the ileocecum: clinical features of 51 Japanese patients with Behçet’s disease. J Tokyo Wom Med Univ. 2010;80:132–138.
  • Sakane T, Takeno M, Suzuki N, et al. Behçet’s disease. N Engl J Med. 1999;341:1284–1291.
  • Kastner DL. 2001. Intermittent and periodic arthritic syndromes. In: Koopman WJ, editor. Arthritis and allied conditions: a textbook of rheumatology. 14th ed. Vol. 1. Baltimore: Williams & Wilkins. p. 1420–1429.
  • Suzuki MK, Suzuki N. Behcet’s disease. Clin Exp Med. 2004;4:10–20.
  • Criteria for diagnosis of Behçet’s disease. International Study Group for Behçet’s Disease. Lancet. 1990;335:1078–1080.
  • Kobashigawa T, Okamoto H, Kato J, et al. Ulcerative colitis followed by the development of Behçet’s disease. Intern Med. 2004;43:243–247.
  • Kobashigawa T, Nanke Y, Takazoe M, et al. A case of human leukocyte antigen (HLA) B27-positive intestinal Behçet’s disease with Crohn’s disease-like anal fistulas. Clin Med Insights Case Rep. 2014;27:13–19.
  • Akpolat T, Koç Y, Yeniay I, et al. Familial Behçet’s disease. Eur J Med. 1992;1:391–395.
  • Itoh Y, Inoko H, Kulski JK, et al. Four-digit allele genotyping of the HLA-A and HLA-B genes in Japanese patients with Behcet’s disease by a PCR-SSOP-Luminex method. Tissue Antigens. 2006;67:390–394.
  • Mizuki N, Ohno S, Ando H, et al. A strong association between HLA-B*5101 and Behçet’s disease in Greek patients. Tissue Antigens. 1997;50:57–60.
  • Kaya TI, Dur H, Tursen U, et al. Association of class I HLA antigens with the clinical manifestations of Turkish patients with Behçet’s disease. Clin Exp Dermatol. 2002;27:498–501.
  • Gül A, Uyar FA, Inanç M, et al. A weak association of HLA-B*2702 with Behçet’s disease. Genes Immun. 2002;3:368–372.
  • Ohno S, Aoki K, Sugiura S, et al. Letter: HL-A5 and Behçet’s disease. Lancet. 1973;2:1383–1384.
  • Paul M, Klein T, Krause I, et al. Allelic distribution of HLA-B*5 in HLA-B5-positive Israeli patients with Behçet’s disease. Tissue Antigens. 2001;58:185–186.
  • Spadaro A, Ceccarelli F, Scrivo R, et al. Life-table analysis of etanercept with or without methotrexate in patients with psoriatic arthritis. Ann Rheum Dis. 2008;67:1650–1651.
  • Kaklamani VG, Variopoulos G, Kaklamanis PG. Behçet’s disease. Semin Arthritis Rheum. 1998;27:197–217.
  • Meguro A, Inoko H, Ota M, et al. Genetics of Behçet disease inside and outside the MHC. Ann Rheum Dis. 2010;69:747–754.
  • Kaburaki T, Takamoto M, Numaga J, et al. Genetic association of HLA-A*2601 with ocular Behçet’s disease in Japanese patients. Clin Exp Rheumatol. 2010;28:S39–S44.
  • Matsuki K, Juji T, Tokunaga K, et al. HLA antigens in Behçet’s disease with refractory ocular attacks. Tissue Antigens. 1987;29:208–213.
  • Chung YM, Yeh TS, Sheu MM, et al. Behcet's disease with ocular involvement in Taiwan: a joint survey of six major ophthalmological departments. J Formos Med Assoc. 1990;89:413–417. [Article in Chinese].
  • Kang EH, Kim JY, Takeuchi F, et al. Associations between the HLA-A polymorphism and the clinical manifestations of Behcet’s disease. Arthritis Res Ther. 2011;13:R49.
  • Kang EH, Park JW, Park C, et al. Genetic and non-genetic factors affecting the visual outcome of ocular Behcet’s disease. Hum Immunol. 2013;74:1363–1367.
  • Asako K. Association of HLA-A26 with Behcet’s disease in Japanese patients. Clin Rheumatol. 2011;23:29–36. [Article in Japanese].
  • Kimura Y, Asako K, Kikuchi H, et al. Characteristics of patients with intestinal Behçet’s disease requiring treatment with immunosuppressants or anti-TNFα antibody. Mod Rheumatol. 2016;26:132–137.
  • Hisamura T, Ueno F, Matsumoto T, et al. The 2nd edition of consensus statements for the diagnosis and management of intestinal Behçet’s disease: indication of anti-TNF alpha monoclonal antibodies. J Gastroenterol. 2014;49:156–162.
  • Naganuma M, Sakuraba A, Hisamatsu T, et al. Efficacy of infliximab for induction and maintenance of remission in intestinal Behçet’s disease. Inflamm Bowel Dis. 2008;14:1259–1264.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.